• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A mouse model repository for cancer biomarker discovery.用于癌症生物标志物发现的小鼠模型库。
J Proteome Res. 2008 Aug;7(8):3613-8. doi: 10.1021/pr800210b. Epub 2008 Jul 15.
2
Streamlining biomarker discovery.简化生物标志物发现流程。
Nat Biotechnol. 2011 Jul 11;29(7):600-2. doi: 10.1038/nbt.1917.
3
Systematic, evidence-based discovery of biomarkers at the NCI.在 NCI 进行系统的、基于证据的生物标志物发现。
Clin Exp Metastasis. 2012 Oct;29(7):645-52. doi: 10.1007/s10585-012-9507-z. Epub 2012 Aug 7.
4
Exploration of the platelet proteome in patients with early-stage cancer.早期癌症患者血小板蛋白质组的探索。
J Proteomics. 2018 Apr 15;177:65-74. doi: 10.1016/j.jprot.2018.02.011. Epub 2018 Feb 10.
5
The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification.蛋白质组学中的表面增强激光解吸电离飞行时间质谱方法:蛋白质谱分析与生物标志物鉴定。
Biochem Biophys Res Commun. 2002 Apr 5;292(3):587-92. doi: 10.1006/bbrc.2002.6678.
6
Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.锌 α2-糖蛋白作为一种潜在的新型尿液生物标志物用于前列腺癌的早期诊断。
BJU Int. 2012 Dec;110(11 Pt B):E688-93. doi: 10.1111/j.1464-410X.2012.11501.x. Epub 2012 Sep 28.
7
Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.在乳腺癌小鼠模型中展示的基于质谱的生物标志物发现与确证的整合流程。
J Proteome Res. 2007 Oct;6(10):3962-75. doi: 10.1021/pr070202v. Epub 2007 Aug 21.
8
Urinary biomarkers in prostate cancer detection and monitoring progression.用于前列腺癌检测和监测病情进展的尿液生物标志物。
Crit Rev Oncol Hematol. 2017 Oct;118:15-26. doi: 10.1016/j.critrevonc.2017.08.002. Epub 2017 Aug 19.
9
Pancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models.基于小鼠模型蛋白质组分析的胰腺肿瘤前病变血浆特征及生物标志物
Br J Cancer. 2015 Dec 1;113(11):1590-8. doi: 10.1038/bjc.2015.370. Epub 2015 Oct 29.
10
Proteomics for cancer biomarker discovery.用于癌症生物标志物发现的蛋白质组学。
Clin Chem. 2002 Aug;48(8):1160-9.

引用本文的文献

1
MALDI-TOF MS Analysis of Serum Peptidome Patterns in Cervical Cancer.基质辅助激光解吸电离飞行时间质谱分析宫颈癌血清肽组模式
Biomedicines. 2023 Aug 21;11(8):2327. doi: 10.3390/biomedicines11082327.
2
Proteomic and transcriptomic profiling of Pten gene-knockout mouse model of prostate cancer.前列腺癌 Pten 基因敲除小鼠模型的蛋白质组学和转录组学分析。
Prostate. 2020 May;80(7):588-605. doi: 10.1002/pros.23972. Epub 2020 Mar 12.
3
Pyranocoumarin Tissue Distribution, Plasma Metabolome and Prostate Transcriptome Impacts of Sub-Chronic Exposure to Korean Angelica Supplement in Mice.亚慢性暴露于韩国当归补充剂对小鼠的吡喃香豆素组织分布、血浆代谢组和前列腺转录组的影响
Am J Chin Med. 2016;44(2):321-53. doi: 10.1142/S0192415X16500191.
4
A maximum Likelihood Approach to Analyzing Incomplete Longitudinal Data in Mammary Tumor Development Experiments with Mice.一种用于分析小鼠乳腺肿瘤发育实验中不完全纵向数据的最大似然方法。
Sri Lankan J Appl Stat. 2012;13:61-85. doi: 10.4038/sljastats.v13i0.5124. Epub 2013 Jan 9.
5
Serial analysis of 38 proteins during the progression of human breast tumor in mice using an antibody colocalization microarray.使用抗体共定位微阵列对小鼠体内人乳腺肿瘤进展过程中的38种蛋白质进行系列分析。
Mol Cell Proteomics. 2015 Apr;14(4):1024-37. doi: 10.1074/mcp.M114.046516. Epub 2015 Feb 13.
6
Tumor microenvironment-derived proteins dominate the plasma proteome response during breast cancer induction and progression.肿瘤微环境衍生蛋白主导乳腺癌发生和进展过程中的血浆蛋白质组反应。
Cancer Res. 2011 Aug 1;71(15):5090-100. doi: 10.1158/0008-5472.CAN-11-0568. Epub 2011 Jun 8.
7
Plasma proteome profiles associated with inflammation, angiogenesis, and cancer.与炎症、血管生成和癌症相关的血浆蛋白质组图谱。
PLoS One. 2011 May 12;6(5):e19721. doi: 10.1371/journal.pone.0019721.
8
Proteome and transcriptome profiles of a Her2/Neu-driven mouse model of breast cancer.乳腺癌 Her2/Neu 驱动型小鼠模型的蛋白质组和转录组图谱。
Proteomics Clin Appl. 2011 Apr;5(3-4):179-88. doi: 10.1002/prca.201000037. Epub 2011 Feb 15.
9
Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer.将高通量技术整合到寻找卵巢癌有效生物标志物的研究中。
Nat Rev Cancer. 2010 May;10(5):371-8. doi: 10.1038/nrc2831. Epub 2010 Apr 12.
10
Early detection of breast cancer: new biomarker tests on the horizon?早期乳腺癌检测:新的生物标志物检测方法即将问世?
Mol Diagn Ther. 2009 Dec 1;13(6):349-57. doi: 10.1007/BF03256340.

本文引用的文献

1
Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells.乳腺癌小鼠模型的血浆蛋白质组分析确定了一组与人类乳腺癌细胞共有的上调蛋白。
J Proteome Res. 2008 Apr;7(4):1481-9. doi: 10.1021/pr7007994. Epub 2008 Feb 27.
2
Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future.用于生物标志物发现的体液蛋白质组学:过去的经验是未来成功的关键。
J Proteome Res. 2007 Dec;6(12):4549-55. doi: 10.1021/pr070529w. Epub 2007 Oct 31.
3
Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.在乳腺癌小鼠模型中展示的基于质谱的生物标志物发现与确证的整合流程。
J Proteome Res. 2007 Oct;6(10):3962-75. doi: 10.1021/pr070202v. Epub 2007 Aug 21.
4
How shall we use the proteomics toolbox for biomarker discovery?我们应如何使用蛋白质组学工具箱来发现生物标志物?
J Proteome Res. 2007 Sep;6(9):3371-6. doi: 10.1021/pr0702060. Epub 2007 Jul 27.
5
Tumor progression in Apc(1638N) mice with Exo1 and Fen1 deficiencies.Exo1和Fen1缺陷的Apc(1638N)小鼠中的肿瘤进展
Oncogene. 2007 Sep 20;26(43):6297-306. doi: 10.1038/sj.onc.1210453. Epub 2007 Apr 23.
6
Head-to-head comparison of serum fractionation techniques.血清分离技术的直接比较。
J Proteome Res. 2007 Feb;6(2):828-36. doi: 10.1021/pr0604920.
7
Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers.基于抗体的磁珠肽富集法用于基于质谱的血清生物标志物定量分析
Anal Biochem. 2007 Mar 1;362(1):44-54. doi: 10.1016/j.ab.2006.12.023. Epub 2006 Dec 20.
8
Mass spectrometry: uncovering the cancer proteome for diagnostics.质谱分析:揭示用于诊断的癌症蛋白质组。
Adv Cancer Res. 2007;96:23-50. doi: 10.1016/S0065-230X(06)96002-3.
9
Peptidomics for cancer diagnosis: present and future.用于癌症诊断的肽组学:现状与未来。
J Proteome Res. 2006 Sep;5(9):2079-82. doi: 10.1021/pr060225u.
10
The US Food and Drug Administration perspective on cancer biomarker development.美国食品药品监督管理局对癌症生物标志物研发的观点。
Nat Rev Cancer. 2006 Jul;6(7):565-71. doi: 10.1038/nrc1911.

用于癌症生物标志物发现的小鼠模型库。

A mouse model repository for cancer biomarker discovery.

作者信息

Kelly-Spratt Karen S, Kasarda A Erik, Igra Mark, Kemp Christopher J

机构信息

Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

出版信息

J Proteome Res. 2008 Aug;7(8):3613-8. doi: 10.1021/pr800210b. Epub 2008 Jul 15.

DOI:10.1021/pr800210b
PMID:18624399
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3727967/
Abstract

Early detection of cancer using biomarkers obtained from blood or other easily accessible tissues would have a significant impact on reducing cancer mortality. However, identifying new blood-based biomarkers has been hindered by the dynamic complexity of the human plasma proteome, confounded by genetic and environmental variability, and the scarcity of high quality controlled samples. In this report, we discuss a new paradigm for biomarker discovery through the use of mouse models. Inbred mouse models of cancer recapitulate many critical features of human cancer, while eliminating sources of environmental and genetic variability. The ability to collect samples from highly matched cases and controls under identical conditions further reduces variability which is critical for successful biomarker discovery. We describe the establishment of a repository containing tumor, plasma, urine, and other tissues from 10 different mouse models of human cancer, including two breast, two lung, two prostate, two gastrointestinal, one ovarian, and one skin tumor model. We present the overall design of this resource and its potential use by the research community for biomarker discovery.

摘要

利用从血液或其他易于获取的组织中获得的生物标志物进行癌症的早期检测,将对降低癌症死亡率产生重大影响。然而,人类血浆蛋白质组的动态复杂性、遗传和环境变异性的干扰以及高质量对照样本的稀缺,阻碍了新型血液生物标志物的识别。在本报告中,我们讨论了一种通过使用小鼠模型发现生物标志物的新范式。癌症近交系小鼠模型概括了人类癌症的许多关键特征,同时消除了环境和遗传变异性的来源。在相同条件下从高度匹配的病例和对照中收集样本的能力进一步降低了变异性,这对于成功发现生物标志物至关重要。我们描述了一个储存库的建立,该储存库包含来自10种不同人类癌症小鼠模型的肿瘤、血浆、尿液和其他组织,包括两种乳腺癌、两种肺癌、两种前列腺癌、两种胃肠道癌、一种卵巢癌和一种皮肤肿瘤模型。我们展示了该资源的总体设计及其在生物标志物发现方面可供研究界使用的潜力。